Infinity Announces Senior Management Promotion
May 18, 2010 08:27 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 18, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced the promotion of Vito J....
Infinity Reports R&D Highlights and Announces First Quarter 2010 Financial Results
May 06, 2010 16:00 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., May 6, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today reported recent research and development...
Infinity Announces May 6 Webcast of First Quarter 2010 Financial Results Conference Call
April 29, 2010 06:24 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, announced today that management will host a...
Infinity Initiates Randomized Clinical Trial of IPI-926 in Pancreatic Cancer and Reports New Preclinical Data at AACR
April 21, 2010 08:00 ET
|
Infinity Pharmaceuticals, Inc.
-- Infinity Advances Hedgehog Pathway Inhibitor Into Later Clinical Development --
-- New Preclinical Data in Several Cancer Indications Further Support Broad Therapeutic Potential of IPI-926 --...
Infinity to Present New Preclinical Data From Its Hedgehog Pathway Inhibitor Program at AACR Meeting
April 08, 2010 10:18 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., April 8, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced that members of its scientific...
Infinity's Innovative Hedgehog Pathway Inhibitor Program to be Highlighted at Upcoming Conferences
March 10, 2010 06:48 ET
|
Infinity Pharmaceuticals, Inc.
-- Julian Adams, Ph.D., President of R&D and CSO, to Present at New York City Academy of Sciences' "Hedgehog Pathway in Cancer" Symposium --
-- Infinity Scientists Also to Discuss Hedgehog...
Infinity to Present at Cowen Health Care Conference
March 02, 2010 23:09 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., March 2, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Gerald E. Quirk,...
Infinity Announces Presentations at Upcoming Lung Cancer Meeting
February 23, 2010 09:17 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that presentations...
Infinity Initiates Clinical Development of Its Fourth Drug Candidate and Announces 2009 Financial Results
February 10, 2010 16:00 ET
|
Infinity Pharmaceuticals, Inc.
Clinical Investigation Initiated for IPI-940 With Broad Potential in Neuropathic and Inflammatory Pain
Financially Strong With Sufficient Capital to Fund Its Operating Plan Into 2013
CAMBRIDGE,...
Infinity Announces 2009 Financial Results Conference Call
February 03, 2010 08:36 ET
|
Infinity Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Feb. 3, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that management will host...